| 1 |
|
| 2 |
Maryam Asadi, Razie Kiani, Vahid Razban, Seyed Nooreddin Faraji, Amirhossein Ahmadi, Jafar Fallahi, Amin Ramezani, Nasrollah Erfani
(2023)
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies
Iranian Journal of Immunology: 20; 410-426
|
| 3 |
|
| 4 |
Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khoram, Amirhossein Ahmadi, Michel Hamblin, Amir Reza Aref, Reza Vafadar, Fatemeh Rezaei-tazangi, Masoud Ghanaatian, Payam Baziyar
(2023)
Receptor tyrosine kinase inhibitors in cancer
CELLULAR AND MOLECULAR LIFE SCIENCES: 80; 104
|
| 5 |
MohammadKhalil pazir, Sajjad Pourmozafar, Ivone Giffard Mena, ًRen Shengjie, Amirhossein Ahmadi, ّIssa Sharifpour
(2022)
Black gill disease in Litopenaeus vannamei made by various agents
Aquaculture and Fisheries: 2022; 1-11
|
| 6 |
Nasim Ebrahimi, Jamileh Saremi, Masoud Ghanatian, Elnaz Yazdani, Samaneh Adelian, Amirhossein Ahmadi, Michel Hamblin, Amir Reza Aref, Sahar Samsami, Neda Moradi
(2022)
The role of endoplasmic reticulum stress in the regulation of long noncoding RNAs in cancer
JOURNAL OF CELLULAR PHYSIOLOGY: 237; 3752
|
| 7 |
Nasim Ebrahimi, Sahar Parkhideh, Setare Samizade, Alireza Nasr Esfahani, Sahar Samsami, Amirhossein Ahmadi, Samaneh Adelian, Elnaz Yazdani, Amir Reza Aref, Siavash Rahimian Chaleshtori, Kamal Shah Amiri
(2022)
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer
CYTOKINE & GROWTH FACTOR REVIEWS: 65; 61-74
|
| 8 |
Seyed Ali Miraghel, Nasim Ebrahimi, Leyla Khani, Atena Mansouri, Asieh Jafarzadeh, Amirhossein Ahmadi, Amir Reza Aref
(2022)
Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer
PHARMACOLOGICAL RESEARCH: 176; 106041
|
| 9 |
MohammadKhalil pazir, Amirhossein Ahmadi, Parisa Hossein Khezri
(2022)
The effect of COVID-19 pandemic on the shrimp industry of Iran
MARINE POLICY: 136; 104900
|
| 10 |
ُTahereh Dadgar, Nasim Ebrahimi, Amir reza Gholipour, Maryam Akbari, Leyla Khani, Amirhossein Ahmadi, Michel Hamblin
(2022)
Targeting the metabolism of cancer stem cells by energy disruptor molecules
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY: 169; 103545
|
| 11 |
Amirhossein Ahmadi, Juan D. Gispert, Arcadi Navarro, Natalia Vilor-Tejedor, Iman Sadeghi
(2021)
Single-cell Transcriptional Changes in Neurodegenerative Diseases
NEUROSCIENCE: 479; 192-205
|
| 12 |
Mohammad Azadbakht, Ali Sayadmanesh, Naghmeh NAzer, Amirhossein Ahmadi, sara Hemmati, Marzieh Ebrahimi, Hossein Baharvand, Babak Khalaj, Mahmoud Reza Aghamaali, Mohsen Basiri, Hoda Mohammadzadeh
(2021)
CRISPRi-mediated knock-down of PRDM1/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells
BioImpacts: 12; 337-347
|
| 13 |
Nasim Ebrahimi, Maryam Akbari, Masoud Ghanatian, Parichehr Roozbahani Moghadam, Samaneh Adelian, Amirhossein Ahmadi, Marzieh Borjian Boroujeni, Elnaz Yazdani, Michel Hamblin
(2021)
Development of neoantigens: from identification in cancer cells to application in cancer vaccines
Expert Review of Vaccines: 1; 1
|
| 14 |
|
| 15 |
|
| 16 |
Shayan Ziaei, Maryam Hosseindokht, Sara Cheraghi, Leyla Pourgholi, Amirhossein Ahmadi, Saeid Sadeghian, Seyed Hesameddin Abbasi, Tahereh Davarpasand, Mohammad Ali Boroumand
(2020)
Predictive Inflammation-related microRNAs for Cardiovascular Events Following Early-Onset Coronary Artery Disease
ARCHIVES OF MEDICAL RESEARCH: 2020; 1-7
|
| 17 |
|
| 18 |
Amirhossein Ahmadi, , , ,
(2020)
Transposable elements in brain health and disease
AGEING RESEARCH REVIEWS: ; ،3
|
| 19 |
|
| 20 |
|
| 21 |
|